Production of TNF by Monocytes of Patients with Early Rheumatoid Arthritis is Increased

References

• Saklatvala J, Sarsfield J SJ, Townsend Y. Pig interleukin-1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation and fever. J Exp Med 1985; 162: 1208–15
   PubMed Web of Science ®Google Scholar
• Bertolini D R, Nedwin G E, Bringman T S, Smith D D, Mundy G R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319: 516–8
   PubMed Web of Science ®Google Scholar
• Firestein G S, Zvaifler N J. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. Arthritis Rheum 1987; 30: 857–63
   PubMedGoogle Scholar
• Seitz M, Hunstein W. Enhanced prostaglandin release from monocytes of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1985; 44: 438–45
   PubMed Web of Science ®Google Scholar
• Shore A, Jaglal S, Keystone S EC. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986; 65: 293–302
   PubMed Web of Science ®Google Scholar
• Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-l/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991; 87: 463–9
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Teppo A M. Cachectin/tumour necrosis factor-alpha in the circulation of patients with rheumatic disease. Int J Tissue React 1989; 11: 189–93
   PubMedGoogle Scholar
• Saxne T, Palladino M A, Jr, Heinegård D, Talal N, Wollheim F A. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041–5
   PubMed Web of Science ®Google Scholar
• Danis V A, Franic G M, Rathjen D A, Laurent R M, Brooks P M. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis 1992; 51: 946–50
   PubMed Web of Science ®Google Scholar
• Philip R, Epstein L B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 1986; 323: 86–9
   PubMed Web of Science ®Google Scholar
• Kuroki T, Shingu M, Koshihara Y, Nobunaga M. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Br J Rheumatol 1994; 33: 224–30
   PubMedGoogle Scholar
• Paimela L, Johansson-Stephansson E A, Koskimies S, Leirisalo-Repo M. Depressed cellular immunity in early rheumatoid arthritis. Clin Exp Rheumatol 1990; 8: 433–7
   PubMed Web of Science ®Google Scholar
• Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 1991; 34: 815–21
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M, Paimela L, Koskimies S, Repo H. Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation 1993; 17: 427–42
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Kunkel S L, Chensue S W, Phan S H. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 1986; 136: 186–92
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M, Jäättelä M, Gylling H, Miettinen T A, Repo H. Phagocyte function in familial hypercholesterolaemia: Peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor generation. Scand J Immunol 1990; 32: 679–85
   PubMed Web of Science ®Google Scholar
• Jäättelä M, Kuusela P, Saksela E. Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest 1988; 58: 48–52
   PubMed Web of Science ®Google Scholar
• Beutler B, Tkacenko V, Milsark I W, Krochin N, Cerami A. The effect of interferon-gamma on cachectin expression by mononuclear phagocytes: reversal of the Ips-d (endotoxin resistance) phenotype. J Exp Med 1986; 164: 1791–6
   PubMed Web of Science ®Google Scholar
• Collart M A, Berlin D, Vassalli J D, De Kossodo D, Vassalli P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986; 164: 2113–8
   PubMed Web of Science ®Google Scholar
• Kornbluth R S, Gregory S A, Edington T S. Initial characterization of lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells. J Immunol 1988; 141: 2006–15
   PubMed Web of Science ®Google Scholar
• Sadouk M, Vaquero C, de la Tour B, Amor B, Toubert A. Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients. Clin Immunol Immunopathol 1990; 56: 37–45
   PubMedGoogle Scholar
• Ruschen S, Stellberg W, Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol 1992; 89: 32–7
   PubMed Web of Science ®Google Scholar
• Zangerle P F, De Groote D, Lopez M, Meuleman R J, Vrindts Y, Fauchet F, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma, GM-CSF) in whole blood: Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992; 4: 568–75
   PubMed Web of Science ®Google Scholar
• Brennan F M, Gibbons D L, Mitchell T, Cope A P, Maini R N, Feldmann M. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol 1992; 22: 1907–12
   PubMed Web of Science ®Google Scholar
• Barrera P, Boerbooms A MT, Janssen E M, Sauerwein R W, Gallati H, Mulder J, et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993; 36: 1070–9
   Google Scholar
• Chu C Q, Field M, Feldmann M, Maini R N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1125–32
   PubMed Web of Science ®Google Scholar
• Miller V E, Rogers K, Muirden K D. Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods. Rheumatol Int 1993; 13: 77–82
   PubMed Web of Science ®Google Scholar
• Deleuran B W, Chu C Q, Field M, Brennan F M, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum 1992; 35: 1170–8
   PubMed Web of Science ®Google Scholar
• Cope A P, Aderka D, Doherty M, Englemann H, Gibbons D, Jones A C, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992; 35: 1160–9
   PubMed Web of Science ®Google Scholar
• Heilig B, Wermann M, Gallati H, Brockhaus M, Berke B, Egen O, et al. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investig 1992; 70: 22–7
   PubMedGoogle Scholar
• Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4025–31
   PubMed Web of Science ®Google Scholar
• Elliott M J, Maini R N, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36: 1681–90
   PubMed Web of Science ®Google Scholar
• Hahn G, Stuhlmuller B, Hain N, Kalden J R, Hzenmaier K, Burmester G R. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 1993; 91: 862–70
   PubMed Web of Science ®Google Scholar
• Franchimont F, Reuter A, Vrindts-Gevaert Y, Bastings M, Malaise M, Sondag C, et al. Production of tumour necrosis factor-alpha and interleukin-2 by peripheral blood mono nuclear cells of subjects suffering from rheumatoid arthritis. Scand J Rheumatol 1988; 17: 203–12
   PubMed Web of Science ®Google Scholar
• Repo H, Lauhio A, Jäättelä M, Saikku P, Leirisalo-Repo M. Peripheral blood monocytes from patients with reactive arthritis show normal production of tumour necrosis factor-alpha. Clin Exp Immunol 1991; 83: 516–7
   PubMed Web of Science ®Google Scholar